Cancer/Oncology

Active Projects: 180

Project Investigator All Topics Start date End date
(PQC4) Fate of cells disseminating from human breast cancer xenografts Zena Werb, PhD Cancer/Oncology, Risk Reduction and Prevention
CC#14952: Phase IB Study of MK-3475 in Subjects with Select Advanced Solid Tumors Hope Rugo, MD Cancer/Oncology, Pharmacology and Drug Treatment
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women Anna-Barbara Moscicki, MD Cancer/Oncology, Women's Health
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
The PROMOTE Program: Precision Oncology and Molecular Targeting in Advanced Prostate Cancer Advancing the Promise of the PCF/SU2C/AACR West Coast Prostate Cancer Dream Team Eric J. Small, MD Cancer/Oncology
Murine Neuroblastoma Models for Preclinical Therapeutics William Weiss, MD, PhD Cancer/Oncology, Drug and Diagnostics Development
Clinical Investigator Research Program for Pilot Research Eric J. Small, MD Cancer/Oncology
Natural History of HPV in Teens-Infection to Neoplasia Stephen Shiboski, PhD Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk Elad Ziv, MD Cancer/Oncology, Women's Health
Genetic Susceptibility to Pediatric Glioma in Individuals and Diverse populations Joseph Wiemels, PhD Cancer/Oncology, Pediatrics
CARAVAN: Checkpoint-Radiation-Vaccine Neoadjuvant Trial for Metastatic Prostate Cancer Lawrence Fong, MD Cancer/Oncology
East Africa IEDEA Regional Consortium Craig Cohen, MD, MPH HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment
Real-World Treatment Patterns and Associated Outcomes Among Patients with Advanced Progressive Pancreatic Neuroendocrine Tumors Emily Bergsland, MD Cancer/Oncology
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy Claudia Petritsch, PhD Cancer/Oncology
Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer Laura J. Esserman, MD Cancer/Oncology, Women's Health
Treatment Decision Making Involvement in Adolescents and Young Adults With Cancer Kimberly A. Pyke-Grimm, RN, MN, CNS Cancer/Oncology, Adolescent Health
Probing Tumor Metastasis through Chemical Cell Surface Engineering Valerie M. Weaver, PhD Cancer/Oncology, Immunology
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myelodysplastic Syndrome Kevin M. Shannon, MD Cancer/Oncology
UCSF-GIVI Center for AIDS Research (CFAR) Paul A. Volberding, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians
Molecular Genetics of Liver Cancers Xin Chen, PhD Cancer/Oncology, Genetics
Obesity, Body Fat Distribution and Cancer Risk in the Multiethnic Cohort (Core C) John A. Shepherd, PhD Cancer/Oncology, Diet, Exercise, and Obesity
Phase II Trial of Targeted Kinase Fusion Inhibition in Unresectable Stage III/IV BRAF/NRAS Wild-Type Melanoma Cancer/Oncology
Translational development of a novel antibody-drug conjugates against myeloma Bin Liu, PhD Cancer/Oncology, Immunology
Improving outcomes for JMML (juvenile myelomonocytic leukaemia) through targeted therapeutics Mignon Loh, MD Cancer/Oncology, Pediatrics
The Breast Cancer Clinical Trials Consortium Hope Rugo, MD Cancer/Oncology, Women's Health
Monitoring Physical Activity During Chemotherapy Among Breast Cancer Patients: A Needs Assessment to Develop Interventions to Help Prevent Functional Decline Laura J. Esserman, MD Cancer/Oncology, Women's Health
A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination with Bevacizumab versus Sunitinib in Patients with Untreated Advanced Renal Cell Carcinoma Lawrence Fong, MD Cancer/Oncology
Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment Eric J. Small, MD Cancer/Oncology, Pharmacology and Drug Treatment
Phase III Study Evaluating Palbociclib (PD-0332991), a Cycline-Dependent Kinase (CDK) 4/6 Inhibitor in Patients with Hormone-Receptor-Positive, HER2-Normal Primary Breast Cancer with High Relapse Risk after Neoadjuvant Chemotherapy "Penelope" Hope Rugo, MD Cancer/Oncology, Women's Health
Targeting MYC-Driven Cell Cycle Progression in Neuroendocrine Prostate Cancer with Gallium Citrate PET as a Novel Biomarker of MYC Transcriptional Activity Rahul R. Aggarwal, MD Cancer/Oncology, Drug and Diagnostics Development
The gut microbiome: an unexpected contributor to cancer drug resistance Peter J. Turnbaugh, PhD Cancer/Oncology, Immunology, Pharmacology and Drug Treatment
Hedgehog signaling and signal transduction Thomas B. Kornberg, PhD Cancer/Oncology
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness Frank McCormick, PhD, FRS Cancer/Oncology, Immunology
Metabolic Reprogramming in Brain Tumors Sabrina M. Ronen, PhD Cancer/Oncology
A Phase II, Open Study of the Clinical Activity, Safety and Tolerability of Lapatinib in Combination with Bevacizumab in Subjects with Advanced or Metastatic ErbB-2-Overexpressing Breast Cancer Hope Rugo, MD Cancer/Oncology, Women's Health
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis John A. Shepherd, PhD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Risk Reduction and Prevention
Study of Paclitaxel eith GDC-0941 vs Paclicaxel with placebo in patients with locally recurrent or Metastatic Breast Cancer Michelle E. Melisko, MD Cancer/Oncology, Women's Health
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy Martin McMahon, PhD Cancer/Oncology
Molecular Methods for Cervical Cancer Screening in HIV+ Women Nancy Hessol, MSPH Cancer/Oncology, Drug and Diagnostics Development, Women's Health
The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application Charles J. Ryan, MD Cancer/Oncology
Phase II Study of MK-3475 with and without Bevacizumab for Recurrent Glioblastoma Jennifer L. Clarke, MD, MPH Cancer/Oncology, Pharmacology and Drug Treatment
Negative feedback signaling in tyrosine kinase-driven leukemia Markus Muschen, MD, PhD Cancer/Oncology
Targeting BCL6 in tyrosine kinase-driven leukemia Markus Muschen, MD, PhD Cancer/Oncology
Three Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) Alan P. Venook, MD Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment
PNOC-002: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children with Recurrent/Refractory BRAFV600E-mutant gliomas Michael D. Prados, MD Cancer/Oncology, Pharmacology and Drug Treatment, Pediatrics
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
Physical and Genetic Interaction Landscape of the Tyrosine Kinome Nevan J. Krogan, PhD, MSc Cancer/Oncology, Diabetes, Immunology
Head and Neck Cancer as a Model for Bedside-to-Bench Research Cancer/Oncology
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women (UCSF sub-in) Heike Thiel De Bocanegra, MPH, PhD Cancer/Oncology, Women's Health
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging
Metastatic escape mechanisms in TKI resistant lung cancer Cancer/Oncology
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer Eric J. Small, MD Cancer/Oncology
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development
Perinatal Immune Development and Risk of Childhood Acute Lymphoblastic Leukemia Joseph Wiemels, PhD Cancer/Oncology, Pediatrics
DLM-10-001: An Open-Label, Single Arm, Safety and Tolerability Dose-escalation Study of DAG in Patients with Recurrent Malignant Glioma or Progressive Secondary Brain Tumor Nicholas Butowski, MD Cancer/Oncology
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods Daniel Vigneron, PhD Cancer/Oncology
A Phase I/II Study Evaluating Microwave Hyperthermia and Thermodox (Lyso-Thermosensitive Liposomal Doxorubicin) in Patients with Breast Cancer Recurrence at the Chest Wall (DIGNITY) Hope Rugo, MD Cancer/Oncology, Women's Health
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Exposomic approach to understand the effect of immigration and genetic ancestry on breast cancer risk in U.S. Latinas Laura Fejerman, PhD Cancer/Oncology, Occupational and Environmental Disease
A Biophysical Perspective of Breast Cancer Metastasis and Treatment Resistance Valerie M. Weaver, PhD Cancer/Oncology, Women's Health
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers Laura J. Esserman, MD Cancer/Oncology, Women's Health
Targeting KRAS Mutant Lung Cancers Frank McCormick, PhD, FRS Cancer/Oncology
Prostate Cancer Foundation Young Investigator Award Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET) Kathleen P. Tebb, PhD Infectious Disease, Cancer/Oncology
Testing Targeted Therapy in Philadelphia Chromosome-Like (Ph-Like) All Mignon Loh, MD Cancer/Oncology, Drug and Diagnostics Development
A Novel Targeted Therapy for Medulloblastoma Jeremy F. Reiter, MD, PhD Cancer/Oncology
A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects with Previously Treated Locally Advanced Unresectable or Metastatic (Stage IV) Mismatched Repair Deficient or Microsatellite Instability-High Colorectal Carcinoma (KEYNOTE-164) Cancer/Oncology
An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer Charles J. Ryan, MD Cancer/Oncology
ANCHOR (Anal Cancer/HSIL Outcomes Research) Study (AMC Supplement Administrative Core) Joel Palefsky, MD Cancer/Oncology
Service Agreement - HALO-109-301 Study Margaret A. Tempero, MD Cancer/Oncology, Pharmacology and Drug Treatment
BGJ398X2201 - A Phase 2, multicenter, open-label study of BGJ398 in patients with recurrent resectable or unresectable Glioblastoma Nicholas Butowski, MD Cancer/Oncology
A Single Arm, Open-Label, Phase 2 Study of MGAH22 (Fc-Optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Relapsed or Refractory Advanced Breast Cancer Whose Tumors Express HER2 at the 2+ Level by Immunohistochemistry and Lack Evidence Hope Rugo, MD Cancer/Oncology
An Open-label, Multi-center, Extension Study of NKTR 102 in Subjects Previously Enrolled in NKTR-102 Studies Pamela N. Munster, MD Cancer/Oncology
The goal of this clinical trial is to show that incorporating ofatumumab instead of rituximab in combination with etoposide and cytarabine (OVA) is successful in collecting autologous stem cells for use in an autologous stem cell transplantation (autoSCT) Charalambos (Babis) Andreadis, MD Cancer/Oncology
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Natural History of HPV in Teens-Infection to Neoplasia Stephen Shiboski, PhD Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health
The Mechanistic Effects of Th2 and Th17 Lung Inflammation on Metastasis Stephen W. Jones, PhD Cancer/Oncology, Chronic Respiratory Disease
A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer Rahul R. Aggarwal, MD Cancer/Oncology, Pharmacology and Drug Treatment
Phase 3 study of PD-0332991 (Oral CDK4/6 inhibitor) plus Letrozole versus placebo plus Letrozole for postmenopausal women with ER (+), HER2 (-) breast cancer who have not received prior systemic anti cancer therapies Hope Rugo, MD Cancer/Oncology, Women's Health
Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia Markus Muschen, MD, PhD Cancer/Oncology
Thai Red Cross S&S, HPV TA008 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Cancer/Oncology
UCSF Team, The genetic, epigenetic, and immunological underpinnings of cancer evolution through treatment Steven J. Altschuler, PhD Cancer/Oncology, Genetics
Epigenetic Regulation of Pancreatic Cancer Matthias Hebrok, PhD Cancer/Oncology
ARID5B and Disparities of Childhood Leukemia Mignon Loh, MD Cancer/Oncology, Pediatrics
Phase 3 trial Of Fulvestrant with or without Palbociclib +/- Goserelin in women with hormone receptor-positive, Her2-negative metastatic breast cancer whose disease progressed after prior endocrine therapy Hope Rugo, MD Cancer/Oncology, Women's Health
Impact of Low IL-10 Levels at Birth and Leukemia Risk Joseph Wiemels, PhD Cancer/Oncology, Immunology
Surveillance Markers for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer Laura J. Esserman, MD Cancer/Oncology, Women's Health
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Norah A. Terrault, MD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
Functional Manipulation of Memory Regulatory T cells in Skin Cancer/Oncology, Immunology
MYCN, mTOR and translation control in medulloblastoma William Weiss, MD, PhD Cancer/Oncology, Pediatrics
Dissecting Translational Control of Cancer Progression Cancer/Oncology
Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia Ophir Klein, MD, PhD Cancer/Oncology
International Clinical Research Fellowship Christopher C. Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Drugging the Switch-II Pocket of K-Ras Kevan Shokat, PhD Cancer/Oncology
Evaluating a community-driven cervical cancer prevention model in western Kenya Megan J. Huchko, MD HIV/AIDS, Cancer/Oncology, Women's Health
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells Wendell A. Lim, PhD Cancer/Oncology
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer Jeffrey N. Martin, MD, MPH HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Modeling the Impact of Targeted Therapy Based on Breast Cancer Subtypes Laura J. Esserman, MD Cancer/Oncology, Women's Health
Molecular and Cellular Mechanisms in Cancer Zena Werb, PhD Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
A Phase 2, 2-Stage, 2-Cohort Study of BMN 673 Administered to Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer. Hope Rugo, MD Cancer/Oncology
Developing an breast FNA biopsy service in Trujillo Peru Ronald Balassanian, MD Cancer/Oncology, Drug and Diagnostics Development, Women's Health
Phase II, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutumide with Trastuzumab in Subjects with Her2+ AR+ Metastatic or Locally Advanced Breast Cancer Hope Rugo, MD Cancer/Oncology, Women's Health
A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CB-5083 in Patients with Advanced Solid Tumors Pamela N. Munster, MD Cancer/Oncology
A Phase 3, Open-Label, Randomized, Parallel, 2-Arm, Multi-Center Study of BMN 673 versus Physician's Choice in Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer, Who Have Received No More than 2 Prior Chemotherapy Hope Rugo, MD Cancer/Oncology, Pharmacology and Drug Treatment
A Technological Platform for the Identification of Serine Proteases in Cancer Charles S. Craik, PhD Cancer/Oncology, Drug and Diagnostics Development
Phase 2 Study of Ruxolitinib or Placebo in Combination with Capecitabine in Subjects with Advanced or Metastatic HER2-Negative Breast Cancer. Hope Rugo, MD Cancer/Oncology, Women's Health
Phase I Study to Evaluate the Tolerability, Safety and Efficacy of BMN-673 in Combination with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumor Malignancies that have BRCA Mutations or Triple Negative Metastatic Breast Cancer Pamela N. Munster, MD Cancer/Oncology
Phase 1b/2 Study of MLN0128 (Dual TORC 1/2 Inhibitor) with Exemestane or Fulvestrant Therapy in Postmenopausal with ER+/HER2- Advanced or Metastatic Breast Cancer that has Progressed on Treatment With Everolimus in Combination With Exemestane or Fulvestra Hope Rugo, MD Cancer/Oncology, Women's Health
Targeting BET-bromodomains in neuroblastoma William Weiss, MD, PhD Cancer/Oncology, Drug and Diagnostics Development, Pediatrics
A Phase 2 Study of LY2835219 for Patients with Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Hope Rugo, MD Cancer/Oncology, Women's Health
Using Stromal Markers to Improve Risk Stratification of Ductal Carcinoma in Situ Thea D. Tlsty, PhD Cancer/Oncology, Women's Health
Tension-Stat3-miR-mediated metastasis Valerie M. Weaver, PhD Cancer/Oncology, Women's Health
Long distance mentoring in global oncology Anu Agrawal, MD HIV/AIDS, Cancer/Oncology
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma Cancer/Oncology, Pharmacology and Drug Treatment
Clinical Performance, Efficacy and Safety of the DigniCap System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients with Early Stage Breast Cancer Hope Rugo, MD Cancer/Oncology
Cervical cancer screening among HIV positive Kenyan women Erin Dainty, MD Cancer/Oncology, Women's Health
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel with or without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma Cancer/Oncology, Drug and Diagnostics Development
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis Zena Werb, PhD Cancer/Oncology, Women's Health
Surgical and cancer screening capacity building Loie Sauer, MD Surgery and Anesthesia, Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building
Breast cancer risk assessment, screening and prevention Jeffrey A. Tice, MD Cancer/Oncology, Women's Health
Head and neck cancers in LMIC Rahul Seth, MD Surgery and Anesthesia, Cancer/Oncology
Pharmacogenomics of Microtubule Targeting Agents Deanna L. Kroetz, PhD Cancer/Oncology, Drug and Diagnostics Development
Immunotherapy of human bladder cancer Lawrence Fong, MD Cancer/Oncology
International Society of Pediatric Oncology (SIOP) Pediatric Oncology in Developing Countries(PODC) Linda Abramovitz, RN, MS Cancer/Oncology
Twinning Black Lion Hospital in Addis Ababa, Ethiopia Linda Abramovitz, RN, MS Cancer/Oncology, Pediatrics, Training International Scholars and Clinicians
CD36-dependent stromal signaling orchestrates acquisition of pro-tumorigenic phenotypes Thea D. Tlsty, PhD Cancer/Oncology, Women's Health
I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging And Molecular Analysis): An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy Laura J. Esserman, MD Cancer/Oncology
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
A Phase 1 Dose Escalation Study of OMP-52M51 in Subjects with Solid Tumors Pamela N. Munster, MD Cancer/Oncology
Pragmatic Trial of More Versus Less Intensive Strategies for Active Surveillance of Patients with Small Pulmonary Nodules Rebecca Smith-Bindman, MD Cancer/Oncology
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials David Newitt, PhD Cancer/Oncology, Drug and Diagnostics Development
Characterization of a novel role for Hippo-YAP pathway signaling in cancer progression and therapy resistance Trever G. Bivona, MD, PhD Cancer/Oncology
A Technological Platform for the Identification of Serine Proteases in Cancer Charles S. Craik, PhD Cancer/Oncology, Drug and Diagnostics Development
Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG, TBCRC and NABCG intergroup study- TBCRC 029 Hope Rugo, MD Cancer/Oncology
A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Non-small Cell Lung Carcinoma Cancer/Oncology, Pharmacology and Drug Treatment
Training Program in Translational Brain Tumor Research Joseph Costello, PhD Cancer/Oncology
UCSF / Northrop Grumman - Oncology Models Forum Cancer/Oncology
AIDS Malignancy Consortium (AMC) Lawrence D. Kaplan, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)" Cancer/Oncology
Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor Cancer/Oncology, Genetics, Pharmacology and Drug Treatment
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme Nicholas Butowski, MD Cancer/Oncology
A Study of the Safety, Immunopharmacodymics and Anti-TumorActivity of Ibrutinib Combined with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma Margaret A. Tempero, MD Cancer/Oncology, Pharmacology and Drug Treatment
Living Tumor Biopsies to Interrogate Immune Function and Response to Therapy Matthew F. Krummel, PhD Cancer/Oncology
An Expanded Access Protocol of Oral Rociletinib (CO-1686) as Epidermal Growth Factor Receptor (EGFR)-Directed Therapy for Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) with the T790M Resistance Mutation Cancer/Oncology, Pharmacology and Drug Treatment
Phase 1, Dose-Escalation and Expansion, Safety, pK, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation Cancer/Oncology, Pharmacology and Drug Treatment
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis. Jo Chien, MD Cancer/Oncology
ADXS31-142 in Combination with Pembrolizumab (MK-3475) in Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer Lawrence Fong, MD Cancer/Oncology, Pharmacology and Drug Treatment
An Open-Label, Phase 1, Dose Escalation Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Melanoma Cancer/Oncology
A Phase 1 Open-Label, Dose-Finding Study Evaluating Safety and Pharmacokinetics of FPA144 in Patients with Advanced Solid Tumors Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 2 Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma (FLC) Cancer/Oncology
Mount Zion Health Fund - Harold Dobbs Cancer Research Fund Alan P. Venook, MD Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
CC 15957 A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, and Pharmacokinetics of AM0010 in Patients with Advanced Solid Tumors Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 1/1b Study of MGCD516 in Patients with Advanced Solid Tumor Malignancies Cancer/Oncology
Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax®) in Combination with Doxorubicin HCl Liposomal (Doxil®) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-cell Lymphoma Ai Z. Weiyun, MD, PhD Cancer/Oncology
A Phase 2, Randomized, Open-Label, Multicenter, Safety and Efficacy Study of Oral Lucitanib in Patients with FGF Aberrant Metastatic Breast Cancer Hope Rugo, MD Cancer/Oncology, Women's Health
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up Lydia Zablotska, MD, MPA, PhD Cancer/Oncology, Occupational and Environmental Disease
Phase 1b Study of SAR650984 in Combo with Lenalidomide and Dexa for Treatment of Relapsed or Refractory Multiple Myeloma Thomas G. Martin, MD Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment
An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with Her2 Positive (Her2+) Metastatic Breast Cancer Hope Rugo, MD Cancer/Oncology, Women's Health
Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer Katherine Van Loon Steitz, MD, MPH Cancer/Oncology, Drug and Diagnostics Development
A Phase I/IIa Study of Safety and Efficacy of Alpharadin® with Docetaxel in Patients with Bone Metastases From Castration Resistant Prostate Cancer Charles J. Ryan, MD Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer Cancer/Oncology, Pharmacology and Drug Treatment
Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054329 in Subjects With Advanced Malignancies Pamela N. Munster, MD Cancer/Oncology, Drug and Diagnostics Development
A Phase 1, Dose-Escalation/Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Patients with Relapsed/Refractory Multiple Myeloma Cancer/Oncology
A Phase Ib Dose Escalation Trial of Carfilzomib plus Bendamustine and Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Charalambos (Babis) Andreadis, MD Cancer/Oncology, Drug and Diagnostics Development
A Randomized Phase IIB Open Label Study of Nivolumab or Nivolumab in Combination with Ipilimumab Versus Bevacizumab in Adult Subjects with Recurrent Glioblastoma (GBM) Nicholas Butowski, MD Cancer/Oncology
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Phase II Single Agent Study of Selinexor (KPT-330) in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Prior Therapy with Abiraterone Charles J. Ryan, MD Cancer/Oncology
Biological implications of breast cancer protective variants in Latin American women with high Indigenous American ancestry Laura Fejerman, PhD Cancer/Oncology, Women's Health
CC# 159518 A Phase I, First-Time-in-Human Study of MEDI9197, a TLR 7/8 Agonist, Administered Intratumorally in Subjects with a Solid Tumor Cancer Pamela N. Munster, MD Cancer/Oncology, Drug and Diagnostics Development
Phase III Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy vs Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients with Locally Advanced or Metastatic Non Small-Cell Lung Cancer Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects with Glioblastoma Multiforme Nicholas Butowski, MD Cancer/Oncology, Neurology and Mental Health
Phase 1 Open Label, Multi-center Study to Assess the Safety, tolerability and Pharmacokinetics of Orally administered CUDC-907, an HDAC and PI3K Inhibitor in Subjects with Advanced/ Relapsed Solid Tumors Pamela N. Munster, MD Cancer/Oncology, Pharmacology and Drug Treatment
Multiple Myeloma Research Foundation Tissue Banking Agreement Thomas G. Martin, MD Cancer/Oncology
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers Thea D. Tlsty, PhD Cancer/Oncology, Immunology
New Ways of Targeting K-Ras Frank McCormick, PhD, FRS Cancer/Oncology
CC#15987 - Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-meso-19 Gene Therapy Products in Cancer Studies Cancer/Oncology

Active Projects: 304

Project Investigator All Topics Start date End date
Promotoras for Cancer Survivorship-Redes/LAF Eliseo J. Perez-Stable, MD Cancer/Oncology
The Breast and Cervical Cancer Care Coordination and Navigation Program Claire Brindis, DrPH Cancer/Oncology, Women's Health
Women and Infants Transmission Study - Human Papillomavirus Protocol Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health
HPV and AIDS Malignancies Clinical Trials Consortium (AMC) Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
SMART Anal Dysplasia Sub-Study Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Redes En Accion: National Latino Cancer Research Network Eliseo J. Perez-Stable, MD Cancer/Oncology, Immigration and Migration, Engagement in Care
Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer Kimberly Baltzell, RN, PhD, MS Cancer/Oncology, Women's Health
Psychosocial Support Services for Latinas with Breast Cancer Anna M. Napoles, PhD, MPH Cancer/Oncology, Neurology and Mental Health, Women's Health
Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring Peter Carroll, MD Cancer/Oncology
Filipina Breast Cancer Support: Which Model is Meaningful? [2] Nancy J. Burke, PhD Cancer/Oncology
Herpesviral Gene Expression in Kaposi's Sarcoma Donald E. Ganem, MD HIV/AIDS, Cancer/Oncology, Genetics
Sinag Tala (Bright Star): Pilipina Breast Cancer Support Group Outreach Nancy J. Burke, PhD Cancer/Oncology
Mechanisms of Bartonella Virulence in AIDS Patients Jane Koehler, MD HIV/AIDS, Cancer/Oncology, Risk Reduction and Prevention
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles Joel Palefsky, MD Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention
California Division Special Research Scholar Grant in HIV-Related Cancers Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
A Phase II Clinical Trial of Pembrolizumab as Monotherapy for Metastatic Triple-Negative Breast Cancer (mTNBC) Hope Rugo, MD Cancer/Oncology
HPV-Specific T Cell Responses and Anogenital HPV Disease in Women of the WIHS Malcolm D. John, MD HIV/AIDS, Cancer/Oncology, Women's Health
Test characteristics of nipple aspirate fluid cytology for the prediction of breast cancer Jeffrey A. Tice, MD Cancer/Oncology, Women's Health
Affinity Isolation of Direct Kinase Substrates Kevan Shokat, PhD Cancer/Oncology
Molecular Effects of Nutrition Supplements in Prostate Peter Carroll, MD Cancer/Oncology
Biochemistry and Hepatic Toxicity of Carbon Radicals Paul R. Ortiz De Montellano, PhD Cancer/Oncology
Doris Duke Charitable Foundation International Clinical Research Fellowship Program Joel Palefsky, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
A Study Investigating the Association of HPV-Related Biomarkers with the Detection of Anal Precancer And Cancer in HIV-Positive Men Who Have Sex with Men (MSM) Teresa M. Darragh, MD HIV/AIDS, Cancer/Oncology
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Admixture Mapping for Breast Cancer Subtypes Among African American Women Laura Fejerman, PhD Cancer/Oncology, Women's Health
The Cancer Genome Atlas (TCGA) Pilot Program Karen S. Smith-McCune, MD, PhD Cancer/Oncology, Systematic Reviews and Guideline Development
Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia & Related Diseases (NO1-CP-21178) Lydia Zablotska, MD, MPA, PhD Cancer/Oncology, Occupational and Environmental Disease
UCSF Prostate Cancer SPORE Peter Carroll, MD Cancer/Oncology
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Cancer/Oncology, Women's Health
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program Ruth M. Greenblatt, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education
A Workshop on Applications of Mechanistic Information in Human Health Risk Assessment Tracey Woodruff, PhD, MPH Cancer/Oncology, Occupational and Environmental Disease
Cidofovir for Perianal Dysplasia in HIV Patients Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology
Biomarkers that Predict the Response of AIDS-Related Kaposi's Sarcoma to Antiretroviral Therapy and the Risk of Developing Immune Reconstitution Inflammatory Syndrome Stefanie Sowinski, PhD HIV/AIDS, Cancer/Oncology
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Viruses in Breast Fluid: Biomarkers for Breast Cancer? Kimberly Baltzell, RN, PhD, MS Cancer/Oncology, Drug and Diagnostics Development, Women's Health
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [II] Nancy J. Burke, PhD Cancer/Oncology, Patient and Peer Education
Bay Area Breast Cancer and Environment Research Center Robert A. Hiatt, MD, PhD Cancer/Oncology, Women's Health
Filipina Breast Cancer Support: What Model is Meaningful? [1] Nancy J. Burke, PhD Cancer/Oncology
Family History Breast Cancer Education Rena J. Pasick, DrPH Cancer/Oncology, Women's Health
Bay Area Breast Cancer and the Environment Research Center Robert A. Hiatt, MD, PhD Cancer/Oncology, Occupational and Environmental Disease
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
NAAccord (CHK-UP on HIV Supplement) Jeffrey N. Martin, MD, MPH HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
To Discover and Characterize Novel Viruses in Cancer Charles Y. Chiu, MD, PhD Infectious Disease, Cancer/Oncology
Determinants of Participation in an Anal Cancer Prevention Trial Joel Palefsky, MD Cancer/Oncology
Partnership to Advance Breast Cancer Research Tracey Woodruff, PhD, MPH Cancer/Oncology, Occupational and Environmental Disease, Women's Health
Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients with High Grade Glioma Nicholas Butowski, MD Cancer/Oncology, Pharmacology and Drug Treatment
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Probe Development for Prostate Cancer Henry F. Vanbrocklin, PhD Cancer/Oncology
Noninvasive Identifiers of Women with High Breast Density John A. Shepherd, PhD Cancer/Oncology, Women's Health
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women Megan J. Huchko, MD HIV/AIDS, Cancer/Oncology
Taste for the Cure and a Taste of Science Laura J. Esserman, MD Cancer/Oncology, Women's Health
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas Anna M. Napoles, PhD, MPH Cancer/Oncology, Neurology and Mental Health, Women's Health
Paternal Smoking and DNA Methylation in Childhood Leukemia Joseph Wiemels, PhD Cancer/Oncology, Pediatrics, Smoking and Tobacco
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Athena Breast Care Network Laura J. Esserman, MD Cancer/Oncology, Women's Health
New treatments for triple negative breast cancer through the biparatopic inhibition of the uPAR receptor Cancer/Oncology
6th International Workshop on Breast Cancer Risk Assessment John A. Shepherd, PhD Cancer/Oncology, Women's Health
Pharmacogenetics of Chemotherapy-Induced Toxicity in Breast Cancer Deanna L. Kroetz, PhD Cancer/Oncology, Genetics, Pharmacology and Drug Treatment, Women's Health
Alex's Lemonade Stand Foundation Post Program Katherine K. Matthay, MD Cancer/Oncology, Pediatrics
St. Baldrick's Summer Fellowship Michelle L. Hermiston, MD, PhD Cancer/Oncology, Pediatrics, Risk Reduction and Prevention
Open-Label, Expanded Access Protocol of BSI-201 in Combination with Gemcitabine/Carboplatin in Patients with ER-, PR-, and HER2-Negative Metastatic Breast Cancer Hope Rugo, MD Cancer/Oncology, Women's Health
Development of Targeted Anti-Cancer Platinum Analogs Kathleen M. Giacomini, PhD Cancer/Oncology, Drug and Diagnostics Development
Early Detection of Metastasis-Prone Breast Cancers Laura J. Esserman, MD Cancer/Oncology, Drug and Diagnostics Development, Women's Health
Role of Metalloproteinases in Mammary Gland Remodeling Zena Werb, PhD Cancer/Oncology
Children's Oncology Group Acute Lymphoblastic Leukemia High Risk Molecular Markers Mignon Loh, MD Cancer/Oncology
Adult Brain Tumor Consortium (ABTC) Michael D. Prados, MD Cancer/Oncology
Adjuvant Treatment with Temodar plus Avastin Alone or with Tarceva in Patient with Newly Diagnosed Glioblastoma Multiforme Who Are Stable Following Radiotherapy with Temodar Michael D. Prados, MD Cancer/Oncology, Pharmacology and Drug Treatment
Buong Puso: Linking Filipinas with Breast Cancer to Care and Support Resources Nancy J. Burke, PhD Cancer/Oncology
Genome-Wide Predictors of Treatment-Related Toxicities Deanna L. Kroetz, PhD Cancer/Oncology, Women's Health
Colorectal Cancer Screening with FIT during Annual Flu Shot Clinics Michael B. Potter, MD Cancer/Oncology, Engagement in Care, Patient and Peer Education
Prevention and Treatment of Impotence Tom F. Lue, MD Cancer/Oncology, Risk Reduction and Prevention
Sanofi-Aventis SAR650894 Program - Clinical Component Thomas G. Martin, MD Cancer/Oncology, Drug and Diagnostics Development
Sanofi-Aventis SAR650894 Program - Research Component Thomas G. Martin, MD Cancer/Oncology, Drug and Diagnostics Development
Cellular and Genetic Origins of Astrocytes David H. Rowitch, MD, PhD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Neurology and Mental Health, Risk Reduction and Prevention
Reducing Disparities in Colorectal Cancer Screening in Vietnamese Americans Tung T. Nguyen, MD Cancer/Oncology
Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia Markus Muschen, MD, PhD Cancer/Oncology
Breast Cancer Risk Reduction in Primary Care Clinics: A Bilingual Intervention for Women and Physicians Celia P. Kaplan, DrPH Cancer/Oncology, Women's Health
Individually Optimized Conditioning Using PK-directed Dose Adjustment of Once Daily IV Busulfan, Followed by Autologous Hematopoietic Stem Cell Transplant Ai Z. Weiyun, MD, PhD Cancer/Oncology, Pharmacology and Drug Treatment
Metabolic Imaging of the Prostate Using 3-D MRSI Daniel Vigneron, PhD Cancer/Oncology, Risk Reduction and Prevention
HIV and HPV Transmission Across Mucosal Epithelia Sharof Tugizov, PhD HIV/AIDS, Cancer/Oncology
The Kit Signaling Pathway As a Therapeutic Target in Melanoma Boris C. Bastian, MD, PhD Cancer/Oncology
Genetic Analysis of the Nucleosome and RNA Polymerase II: a Systems Approach Nevan J. Krogan, PhD, MSc Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics
Transcriptional Regulation of Breast Cancer Metastasis Zena Werb, PhD Cancer/Oncology, Women's Health
Anal Cytology/HPV Testing Study Joel Palefsky, MD Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development
Admixture Mapping for Breast Cancer in Latinas Elad Ziv, MD Cancer/Oncology, Women's Health
Promotoras for Cancer Survivorship-Redes/LAF Eliseo J. Perez-Stable, MD Cancer/Oncology, Women's Health
The Role of Microenvironment-Mediated CXCR4/CXCL12 Axis in Inducing Chemoresistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Michelle L. Hermiston, MD, PhD Cancer/Oncology, Pediatrics
Phase I Parallel Protocol of MK-8669 (Ridaforolimus) + MK-2206 and MK-8669 (Ridaforolimus) + MK-0752 Doublets (MKMK) in Patients with Advanced Cancer Pamela N. Munster, MD Cancer/Oncology
New Approaches to Neuroblastoma Therapy (NANT) Katherine K. Matthay, MD Cancer/Oncology, Neurology and Mental Health
Prostate Cancer and Pesticides Paul K. Mills, PhD Cancer/Oncology, Occupational and Environmental Disease
Targeting the translational apparatus in MYCN-driven medulloblastoma William Weiss, MD, PhD Cancer/Oncology
A Phase I Study to Assess the Bioequivalence of 2 Formulations of TKI258, FMI Capsule and FMI Tablet, in Patients with Advanced Solid Tumors Pamela N. Munster, MD Cancer/Oncology
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [I] Nancy J. Burke, PhD Cancer/Oncology
Hemoprotein Oxidation and Heme Catabolism Paul R. Ortiz De Montellano, PhD Cancer/Oncology
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors Pamela N. Munster, MD Cancer/Oncology, Pharmacology and Drug Treatment
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas Anna M. Napoles, PhD, MPH Cancer/Oncology, Women's Health
Quality of Mammography Facilities Serving Vulnerable Women Lauren E. Goldman, MD Cancer/Oncology, Women's Health
Biomarkers for Environmental Exposures in Breast Cancer Zena Werb, PhD Cancer/Oncology, Women's Health
Compassionate Use of Marqibo for the Treatment of Refractory Lymphoblastic Leukemia/Leukemia Charalambos (Babis) Andreadis, MD Cancer/Oncology, Pharmacology and Drug Treatment
Fundamental Mechanobiology of Tumor Progression Frank McCormick, PhD, FRS Cancer/Oncology
New Paradigm of Breast Cancer Causation and Prevention Robert A. Hiatt, MD, PhD Cancer/Oncology, Occupational and Environmental Disease
Fundamental Mechanobiology of Tumor Progression Frank McCormick, PhD, FRS Cancer/Oncology
New Paradigm of Breast Cancer Causation and Prevention Robert A. Hiatt, MD, PhD Cancer/Oncology, Women's Health
New Paradigm of Breast Cancer Causation & Prevention Robert A. Hiatt, MD, PhD Cancer/Oncology, Women's Health
Functional Studies on Genetic Variants of PTPN14 Rosemary J. Akhurst, PhD Cancer/Oncology
Molecular and Cellular Mechanisms in Cancer Zena Werb, PhD Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
Development of Transporter Targeted Platinum Drugs for Neuroblastoma Kathleen M. Giacomini, PhD Cancer/Oncology, Neurology and Mental Health
Leveraging the California Cancer Registry to Measure and Improve the Quality of Cancer Care Robert A. Hiatt, MD, PhD Cancer/Oncology, Health Economics and Policy, Epidemiology and Surveillance
Deciphering Cellular Heterogeneity of the Normal Breast to Understand the Origin of Ductal Cancer In Situ (DCIS) Laura J. Esserman, MD Cancer/Oncology, Women's Health
Preclinical Pharmacokinetic and Pharmacological Studies with Anticancer and Other Therapeutic Agents Yong Huang, PhD Cancer/Oncology
Mount Zion Health Fund Transdisciplinary Team Award Eric J. Small, MD Cancer/Oncology
Study of AMG 479 with Exemestane or Fulvestrant in Postmenopausal Women with Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Michelle E. Melisko, MD Cancer/Oncology, Women's Health
A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects with Solid Tumors or Lymphoma Pamela N. Munster, MD Cancer/Oncology
Characterizing Voriconazole-Associated Mechanisms of Carcinogenesis in Human Keratinocytes Cancer/Oncology
Structuring population health sciences within a faculty of health sciences in East Africa Robert A. Hiatt, MD, PhD Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building
TCGA (Cancer Genome Atlas) Michael D. Prados, MD Cancer/Oncology
BEACON Study (BrEAst Cancer Outcomes with NKTR-102): Phase 3 Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with Anthracycline, a Taxane and Capecitabine Hope Rugo, MD Cancer/Oncology, Pharmacology and Drug Treatment, Women's Health
Breast Cancer Risk Reduction: A Patient-Doctor Intervention Celia P. Kaplan, DrPH Cancer/Oncology, Women's Health
Environmental and Molecular Epidemiology of Childhood Leukemia Mignon Loh, MD Cancer/Oncology, Pediatrics
AID-Mediated Genetic Instability in Bcr-Abl1-Transformed B Cell Lineage Leukemia Markus Muschen, MD, PhD Cancer/Oncology
Parsing Out The Role Of PI3'-Kinase Signaling In Lung Cancer Initiation, Progression And Therapy Martin McMahon, PhD Cancer/Oncology
Subregional Breast Density and Cancer Risk John A. Shepherd, PhD Cancer/Oncology
Lipogenic Inhibitors in Prevention of Oncogene Induced Liver Cancer Xin Chen, PhD Cancer/Oncology
Molecular Genetics of Liver Cancers Xin Chen, PhD Cancer/Oncology, Genetics
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne F. Luetkemeyer, MD HIV/AIDS, Cancer/Oncology
HPV & Cervix Neoplasia in a Large, Long Term HIV+ Cohort Teresa M. Darragh, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health
Regulation of Genomic Instability in Early Breast Cancer Thea D. Tlsty, PhD Cancer/Oncology, Immunology
A Phase 1B, Multi-Center, Open Label, Dose Escalation Study of Oral LDE225 in Combination with BKM120 in Patients with Advanced Solid Tumors Pamela N. Munster, MD Cancer/Oncology, Women's Health
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors Emily Bergsland, MD Cancer/Oncology, Pharmacology and Drug Treatment
Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard Pamela N. Munster, MD Cancer/Oncology, Pharmacology and Drug Treatment
Fusion Genes As Therapeutic Targets in Malignant Pleural Mesothelioma Il Jin Kim, PhD Cancer/Oncology, Drug and Diagnostics Development
Regulating Proteolysis to Dissect Apoptosis James Wells, PhD Cancer/Oncology
Oncogenic Viral Biomarkers in Nonmalignant Human Breast Tissue Kimberly Baltzell, RN, PhD, MS Cancer/Oncology, Drug and Diagnostics Development, Women's Health
CIBMTR Protocol 09-MRD Christopher C. Dvorak, MD Cancer/Oncology, Pediatrics
Mount Zion Health Fund Scholars Program for Recruitment /Retention of Promising Clinical /Translational Investigators Eric J. Small, MD Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
Creating a Model Integrative Medicine Program for Head and Neck Cancer at the Osher Center Margaret A. Chesney, PhD Cancer/Oncology
Protocol GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir and Ribavarin with or without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive Recurrent Hepatitis C Infection Kathleen P. Tebb, PhD Infectious Disease, Cancer/Oncology
Phase 1 Study of IMC-CS4, a Monoclonal Antibody Targeted to the CSF-1 Receptor (CSF-1R), in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available Hope Rugo, MD Cancer/Oncology
Cell Competition in the Developing Mouse Germline Diana J. Laird, PhD Cancer/Oncology, Family Planning, Pediatrics, Newborn and Infant Health
PAAR4Kids-Pharmacogenomics Research Network Mignon Loh, MD Cancer/Oncology, Genetics, Pharmacology and Drug Treatment
A Phase Ib Dose Escalation/Randomized Phase II, Multicenter, Open-label Study of BYL719 in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Pamela N. Munster, MD Cancer/Oncology
Predicting Early and Late Recurrence to Improve Care Laura J. Esserman, MD Cancer/Oncology, Women's Health
Lay health workers and colorectal cancer screening among Chinese Americans Tung T. Nguyen, MD Cancer/Oncology, Patient and Peer Education
Explosive Evolution Under Stress: the Driving Forces of Cancer Dynamics - Project 2 Thea D. Tlsty, PhD Cancer/Oncology
Explosive Evolution Under Stress: the Driving Forces of Cancer Dynamics - Project 1 Thea D. Tlsty, PhD Cancer/Oncology
Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation. Lydia Zablotska, MD, MPA, PhD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics, Epidemiology and Surveillance, Risk Reduction and Prevention
Center for Interdisciplinary Research on Childhood Leukemia and the Environment John R. Balmes, MD Cancer/Oncology, Occupational and Environmental Disease, Pediatrics
Using Epigenetic Changes to Stratify DCIS Biopsies Thea D. Tlsty, PhD Cancer/Oncology, Women's Health
Environmental effects of the mammary gland across the lifespan Zena Werb, PhD Cancer/Oncology, Occupational and Environmental Disease, Women's Health
Environmental and Molecular Epidemiology of Childhood Leukemia Joseph Wiemels, PhD Cancer/Oncology
Using Epigenetic Changes to Stratify DCIS Biopsies Thea D. Tlsty, PhD Cancer/Oncology, Women's Health
Spirit of Eagles Communities Network Program Neal L. Benowitz, MD Cancer/Oncology
MiRNAs as prognostic markers for prostate cancer patients on active surveillance Robert H. Blelloch, MD, PhD Cancer/Oncology, Drug and Diagnostics Development
Non-Invasive Assessment of Bone Micro-Architecture and Strength Changes in Androgen Deprivation Therapy in Prostate Cancer As a Model for Male Secondary Osteoporosis Sharmila Majumdar, PhD Cancer/Oncology
Redes En Acción: National Latino Cancer Research Network Eliseo J. Perez-Stable, MD Cancer/Oncology
Role of Fibroblasts, Myeloid Cells and Matrix in Pancreatic Ductal Adenocarcinoma (PDAC) Valerie M. Weaver, PhD Cancer/Oncology
Uganda-UCSF Research Training Program in HIV-Associated Malignancies Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Regulation of Mammary Epithelial Signaling by Local Matrix Stiffness Thea D. Tlsty, PhD Cancer/Oncology, Women's Health
Training Program in Translational Brain Tumor Research Russell Pieper, PhD Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
AIDS Malignancies Consortium Lawrence D. Kaplan, MD HIV/AIDS, Cancer/Oncology
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
Human papillomavirus and the impact of needle-free vaccination on incidence in Thai women: a quantitative study Sneh Patel, MS Infectious Disease, Cancer/Oncology, Pediatrics
A comparison of the preferences among HIV+ and low risk women towards Cervical Cancer Screening and Prevention using health utilities: A Quantitative Study Keerthana Anand, MS HIV/AIDS, Cancer/Oncology, Women's Health
Imaging Oncogene Activation and Tumor Development in Genetically Engineered Mice Martin McMahon, PhD Cancer/Oncology
Prenatal Exposures, DNA Methylation & Childhood Leukemia Joseph Wiemels, PhD Cancer/Oncology, Pediatrics
A Study of Etiology of Esophageal Cancer in Tanzania (SEEC-Tanzania) Peter Carroll, MD Cancer/Oncology
Identification and Education of Low-Income Women at Risk for Hereditary Breast Cancer Rena J. Pasick, DrPH Cancer/Oncology, Women's Health, Access or Barriers to Care
Immune and Collagen Basis of Breast Cancer Valerie M. Weaver, PhD Cancer/Oncology, Women's Health
The GNAQ pathway as a therapeutic target in uveal melanoma Boris C. Bastian, MD, PhD Cancer/Oncology
Embryonic signaling pathways in pancreatic cancer Matthias Hebrok, PhD Cancer/Oncology
HIV, Gut Epithelial Cell Turnover and Mucosal Inflammation, and the Risk of Colorectal Neoplasia Ma Somsouk, MD, MAS HIV/AIDS, Cancer/Oncology
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery Joel Palefsky, MD Sexually Transmitted Infections (STIs), Cancer/Oncology
Targeting Adaptive Pathways in Resistant CRPC Eric J. Small, MD Cancer/Oncology
Partnership to Advance Breast Cancer Research Tracey Woodruff, PhD, MPH Cancer/Oncology, Women's Health
Support for a Multiple Myeloma Project Coordinator Cancer/Oncology
Phase IA, Multicenter, Open-label Dose Escalation Study of Oral BYL719, in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene Hope Rugo, MD Cancer/Oncology
JBAL: A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma Nicholas Butowski, MD Cancer/Oncology, Pharmacology and Drug Treatment
International Case-Control Study of Malignant Glioma Margaret R. Wrensch, PhD Cancer/Oncology
Clinical Investigator Research Program for Pilot Research Studies 2014 Eric J. Small, MD Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training
Thai Red Cross S&S, HN177 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
Approaches to Discover and Quantify Apoptotic Biomarkers for Cancer Treatment James Wells, PhD Infectious Disease, Cancer/Oncology, Risk Reduction and Prevention
Prostate Cancer Detection Decision-Making for Low-Income African American Men Rena J. Pasick, DrPH Cancer/Oncology
Phase I Study of INC280 plus Erlotinib in Patients With C-Met Expressing Non-Small Cell Lung Cancer. Cancer/Oncology
A Multicenter Phase I/II Trial of Abiraterone + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer Charles J. Ryan, MD Cancer/Oncology
Lung Cancer Screening: The Views of Patients and Physicians Celia P. Kaplan, DrPH Cancer/Oncology, Chronic Respiratory Disease
A phase I/II, multicenter, open-label dose finding study of oral CFG920 in patients with metastatic castration-resistant prostate cancer Charles J. Ryan, MD Cancer/Oncology
Pathogenesis of HIV-Related Bacillary Angiomatosis Jane Koehler, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Meeting the self-care needs of Latinas after Breast Cancer Anna M. Napoles, PhD, MPH Cancer/Oncology, Women's Health, Access or Barriers to Care, Immigration and Migration
TGF-ß Suppression and Promotion of Mammary Carcinomas Valerie M. Weaver, PhD Cancer/Oncology, Women's Health
UCSF Cutaneous Immunology Core: OSM Project Opportunistic Infection, Cancer/Oncology, Immunology
Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy Youngho Seo, PhD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Risk Reduction and Prevention
Infectious Origins of Childhood Leukemia [II] Markus Muschen, MD, PhD Cancer/Oncology
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery Cancer/Oncology
Cellular and Genetic Basis of Anaplastic Medulloblastoma William Weiss, MD, PhD Cancer/Oncology, Pediatrics
Risk of Squamous Cell Carcinoma in patients treated for basal cell carcinoma with Vicmodegib or other therapies Cancer/Oncology
A Phase I Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan Using Imaging in High Grade Glioma Nicholas Butowski, MD Cancer/Oncology
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology Cancer/Oncology, Immunology
Extracellular Proteolysis as a Molecular Stratification Tool for Cancer Charles S. Craik, PhD Cancer/Oncology
Project 2: Human Melanoma -- Etiology, Progression, and Therapy Boris C. Bastian, MD, PhD Cancer/Oncology
Impact of molecular phenotype on glioma metabolism and growth Sarah Nelson, PhD Cancer/Oncology
Translating a Stress Management Program for Latinas Anna M. Napoles, PhD, MPH Cancer/Oncology, Women's Health, Access or Barriers to Care
Beacon (Breast Cancer Outcomes with Nktr-102): a Phase 3 Study of Nktr-102 Versus Treatment of Physician's Choice in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline, Taxane and Capecitabine Hope Rugo, MD Cancer/Oncology, Women's Health
A Phase II, Single Arm Study of the Use of Steroid-Based Mouthwash to Prevent Stomatitis in Postmenopausal Women with Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated with Everolimus plus Exemestane. Hope Rugo, MD Cancer/Oncology, Women's Health
International Collaborative of prospective studies of HIV and Hepatitis in IDU Stephen Shiboski, PhD Sexually Transmitted Infections (STIs), Cancer/Oncology
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance Martin McMahon, PhD Cancer/Oncology
Breast Cancer and the Environment Research Program Coordinating Center Robert A. Hiatt, MD, PhD Cancer/Oncology
Oncolytic Virus for the Therapy for Children with recurrent medulloblastoma Cancer/Oncology, Pediatrics
Risk-Based Screening: An Initiative to Dramatically Improve Our Approach to Screening and Prevention Laura J. Esserman, MD Cancer/Oncology
Cellular mechanisms of resistance to chemotherapy and the impact of immune modulating therapy, and molecular characterization of circulating tumor cells (CTCs) in patients with advanced breast cancer (ABC) Hope Rugo, MD Cancer/Oncology, Women's Health
Kaiser Permanente Cervical Cancer Prevention (CCaP) Network George F. Sawaya, MD Cancer/Oncology, Women's Health
A Phase II Trial of HKI-272 (Neratinib) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases (TBCRC 022) Michelle E. Melisko, MD Cancer/Oncology, Neurology and Mental Health, Women's Health
Symptoms Clusters in Oncology Patients Receiving Chemotherapy Christine Miaskowski, RN, PhD, FAAN Cancer/Oncology
TBCRC 22: A Phase II Trial of HKI-272 (Neratinib) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast cancer and Brain Metastases Michelle E. Melisko, MD Cancer/Oncology, Neurology and Mental Health, Women's Health
Master Member Agreement: Translational Breast Cancer Research Consortium Hope Rugo, MD Cancer/Oncology, Epidemiology and Surveillance
Maintain a Health Professional Career Opportunity Program Renee Navarro, MD Cancer/Oncology
The Breast Cancer Clinical Trials Consortium Hope Rugo, MD Cancer/Oncology, Women's Health
Effect of an embedded palliative care program on the unmet needs of patients with metastatic breast cancer. Melanie C. Majure, MD Cancer/Oncology, Women's Health
Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer - Core A Cancer/Oncology
SPORE in Head and Neck Cancer - Project 2 Cancer/Oncology
Personal Patient Profile - Prostate (P3P): A Randomized Multi-site Trial Leslie Wilson, PhD, MS Cancer/Oncology
The Meningioma Consortium: Genome-Wide Association Study Joseph Wiemels, PhD Cancer/Oncology
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance Martin McMahon, PhD Cancer/Oncology
Interplay between tension and inflammation in pancreatic tumor progression Valerie M. Weaver, PhD Cancer/Oncology
Decision-Making about CAM Across the Cancer Continuum: An Observational Study Barbara A. Koenig, PhD Cancer/Oncology
Accurate, long-read sequencing with droplet-microfluidic barcoding Adam Abate, PhD Infectious Disease, Cancer/Oncology, Genetics
MR Metabolic Imaging of Response to Targeted Therapies in GBM Sabrina M. Ronen, PhD Cancer/Oncology, Drug and Diagnostics Development
Negative Feedback and oncogene signaling in leukemia Markus Muschen, MD, PhD Cancer/Oncology
Non-Invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer Charles S. Craik, PhD Cancer/Oncology
Medical Scientist Training Program Mark S. Anderson, MD, PhD Noncommunicable and/or Chronic Disease, Cancer/Oncology, Dementia and Cognitive Impairment, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia Markus Muschen, MD, PhD Cancer/Oncology, Pediatrics
Promoting Post-Treatment Self-Management among Latinos with Cancer Anna M. Napoles, PhD, MPH Cancer/Oncology, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination
Fatty acid transporters in cholangiocarcinoma pathogenesis Xin Chen, PhD Cancer/Oncology
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons Nancy Hessol, MSPH HIV/AIDS, Cancer/Oncology
131I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal Katherine K. Matthay, MD Cancer/Oncology
Postdoctoral training in tobacco control Stanton A. Glantz, PhD Cancer/Oncology, Smoking and Tobacco, Residencies, Fellowships, and Postdoctoral Training
Effects of Maraviroc on HIV-related Kaposi Sarcoma Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors Teresa M. Darragh, MD HIV/AIDS, Cancer/Oncology, Women's Health
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors Teresa M. Darragh, MD HIV/AIDS, Cancer/Oncology, Women's Health
Predicting Early and Late Recurrence to Improve Care Laura J. Esserman, MD Cancer/Oncology, Women's Health
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries Joel Palefsky, MD HIV/AIDS, Cancer/Oncology, Women's Health
Breast Cancer Surveillance Consortium Data Resource Karla M. Kerlikowske, MD Cancer/Oncology, Women's Health
Lung Cancer Screening: Development of a Clinic-Based Intervention Celia P. Kaplan, DrPH Cancer/Oncology
Epigenetic Markers of Age and Diurnal Levels of Fatigue during Chemotherapy Kathryn A. Lee, RN, PhD, FAAN Cancer/Oncology, Women's Health
Targeting the c-Met/HGF Axis in acute Myeloid Leukemia Charalambos (Babis) Andreadis, MD Cancer/Oncology
Clinical Investigator Research Program for Pilot Research Studies 2013 Eric J. Small, MD Cancer/Oncology
The role of HDAC2 in hormone therapy resistance Pamela N. Munster, MD Cancer/Oncology
Leukocyte Biomarkers for Predicting Human Breast Cancer Outcomes Matthew F. Krummel, PhD Cancer/Oncology
Elucidating the Fundamental Biology of Memory Regulatory T cells in Skin Cancer/Oncology, Immunology
Enhancing the Efficacy of Chemotherapy in Triple Negative/Basal-like Breast Cancer by Targeting Macrophages Hope Rugo, MD Cancer/Oncology
Tissue Biopsy Samples from Head and Neck Cancers Charles Y. Chiu, MD, PhD Cancer/Oncology, Drug and Diagnostics Development
Genetics of Mammographic Density in Ashkenazi Jews Elad Ziv, MD Cancer/Oncology, Genetics
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response Karla M. Kerlikowske, MD Cancer/Oncology
Regulation and Targets of the DNA Damage Checkpoint David Toczyski, PhD Cancer/Oncology
Risk of hematologic cancers from repeated low-dose diagnostic radiation. Lydia Zablotska, MD, MPA, PhD Cancer/Oncology, Occupational and Environmental Disease
Project 4: Secondary Cancers among NF1 cancer survivors Jean L. Nakamura, MD Cancer/Oncology
Developmental and Hyperactive Ras Tumor SPORE Kevin M. Shannon, MD Cancer/Oncology, Genetics
Comparative Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi Sarcoma without Urgent Indications for Chemotherapy HIV/AIDS, Opportunistic Infection, Cancer/Oncology, Pharmacology and Drug Treatment
Characterization of and Treatment for Chemotherapy Neuropathy Christine Miaskowski, RN, PhD, FAAN Cancer/Oncology, Neurology and Mental Health
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells Mignon Loh, MD Cancer/Oncology, Adolescent Health
Genome wide association study of breast cancer subtype and survival in Latinas Laura Fejerman, PhD Cancer/Oncology, Genetics, Epidemiology and Surveillance
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations Matthew R. Cooperberg, MD Cancer/Oncology, Pharmacology and Drug Treatment
Risk-Based Breast Cancer Screening in Community Settings Karla M. Kerlikowske, MD Cancer/Oncology, Women's Health
UCSF Abundant Life Health Ministry Initiative Rena J. Pasick, DrPH Cancer/Oncology, Cardiovascular Disease, Diabetes, Patient and Peer Education
Microtubule Complexes Involved in Intracellular Transport Ronald D. Vale, PhD Cancer/Oncology
PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment Michelle E. Melisko, MD Cancer/Oncology, Women's Health
Development of a PET prostate specific membrane antigen imaging agent: Preclinical translation Henry F. Vanbrocklin, PhD Cancer/Oncology
Pharmacological hyperactivation of Ras-MAPK signaling to target Ph+ ALL Markus Muschen, MD, PhD Cancer/Oncology, Pediatrics
HPV testing of samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Pancreatic Cancer Research Pilot Project Margaret A. Tempero, MD Cancer/Oncology
Evaluation of Pomalidomide in Combination with High Dose Dexamethasone and Oral Cyclophosphamide in Patients with Relapsed and Refractory Myeloma Thomas G. Martin, MD Cancer/Oncology, Pharmacology and Drug Treatment
Evaluation of Pao Pereira, a natural product of the extract of rainforest tree, in malignant brain tumor cell lines Nicholas Butowski, MD Cancer/Oncology, Drug and Diagnostics Development
Deep Sequencing Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma Raymond J. Cho, MD, PhD Cancer/Oncology
Phase II study of letrozole with or without BYL719 or buparlisib, for the neoadjuvant treatment of postmenopausal women with hormone receptor-positive HER2-negative breast cancer Hope Rugo, MD Cancer/Oncology
Molecular basis for the activation of Met receptor in lung cancer by mutations in the juxtamembrane segment Natalia Z. Jura, PhD Cancer/Oncology
Influence of germ line genetic variation on myeloma progression and survival Elad Ziv, MD Cancer/Oncology
A Causal Role for Asymmetric Cell Division Defects in Glioma Initiation Claudia Petritsch, PhD Noncommunicable and/or Chronic Disease, Cancer/Oncology
Mechanism regulating ErbB signaling network in head and neck cancer Randall H. Kramer, PhD Cancer/Oncology, Immunology
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening Judith M. Walsh-Cassidy, MD, MPH Cancer/Oncology, Access or Barriers to Care, Patient and Peer Education
Dar es Salaam ESCC Case-Control Study Katherine Van Loon Steitz, MD, MPH Cancer/Oncology
Prostate Cancer Therapeutic Clinical Investigation "First in Man" Eric J. Small, MD Cancer/Oncology, Drug and Diagnostics Development
Binding-Site Modeling with Multiple-Instance Machine-Learning Cancer/Oncology, Drug and Diagnostics Development
Breast Cancer Screening and Outcomes in Diverse Populations: Role of Comorbidity Dejana Braithwaite, PhD, MS Cancer/Oncology, Women's Health
Mechanisms and Therapeutics for Glucocorticoid-Resistant Leukemia Keith Yamamoto, PhD Cancer/Oncology
Study of the histone deacetylase inhibitor Panobinostat (LBH589) in combination with standard dose Cytarabine and Daunorubicin for older patients with untreated acute Mmyeloid leukemia or advanced myelodysplasia Charalambos (Babis) Andreadis, MD Cancer/Oncology
Cutting Edge Lineage Tracking of Tumor-Educated Immune Cells Matthew F. Krummel, PhD Cancer/Oncology
Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma Jennifer L. Clarke, MD, MPH Cancer/Oncology, Genetics
Three Center Symposium Margaret A. Chesney, PhD Cancer/Oncology
Identifying neurofibromin-specific regulatory nodes for therapeutic targeting in NF1 Frank McCormick, PhD, FRS Cancer/Oncology
New Paradigm of Breat Cancer Causation and Prevention - Phase II Robert A. Hiatt, MD, PhD Cancer/Oncology, Occupational and Environmental Disease, Women's Health
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment Trever G. Bivona, MD, PhD Cancer/Oncology, Chronic Respiratory Disease
Translational Investigation of KRas & NF1 in Myeloid Leukemia Kevin M. Shannon, MD Cancer/Oncology, Genetics
Tumor Recurrence and Drug Resistance in Non-Small Cell Lung Cancer Through Modulation of the Cytoskeleton and Activation of YAP Cancer/Oncology
Using Comparative Effectiveness Analyses to Optimize Cervical Cancer Screening George F. Sawaya, MD Cancer/Oncology
A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination with Abiraterone in Chemotherapy Naïve Subjects with Bone-Metastatic Castration-Resistant Prostate Cancer Charles J. Ryan, MD Cancer/Oncology
An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 in Patients Previously Treated with T-DM1 in a Genentech-Sponsored T-DM1 Study Hope Rugo, MD Cancer/Oncology, Women's Health
Advanced Methods to Evaluate Extracellular Matrix and Crosslinking in the Tumor Microenvironment Valerie M. Weaver, PhD Cancer/Oncology
Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer Charles J. Ryan, MD Cancer/Oncology
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 with Letrozole in Adult Patients with Advanced ER+ Breast Cancer Pamela N. Munster, MD Cancer/Oncology, Women's Health
Genetic network analysis of cancer targets William Weiss, MD, PhD Cancer/Oncology
A Phase 2 Pilot Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma. Hope Rugo, MD Cancer/Oncology, Women's Health
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI Daniel Vigneron, PhD Cancer/Oncology
Engaging Underserved Women in Health Research Galen Joseph, PhD Cancer/Oncology, Women's Health

Active Investigators: 79